Silverback Therapeutics
ID: 6444227Silverback Therapeutics is a Seattle-based biopharmaceutical company developing ImmunoTAC therapies targeting previously inaccessible disease pathways.
9
Funding Rounds
$444.7m
Money raised
Recent Funding Rounds
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
| Name | Phone | Social networks | |
|---|---|---|---|
| Pe*** Th****** |
|
- |
| Name | Phone | Social networks | |
|---|---|---|---|
| Pe*** Th****** |
|
- | |
| Jo* Ro** | - | - | |
| Sa*** Is**** J.** | - | - | - |
| Vi**** L. Ca*** | - | - | - |
| Ro**** M. He******* | - | - | - |
| La*** Sh***** | - | - | - |
Funding
Funding series
Funding Series Analysis
The company Silverback Therapeutics has raised a total of $116m in funding over 9 rounds.
Key Insights:
- Silverback Therapeutics Series B round, March 2020: $78.5m
- Silverback Therapeutics Series A round, September 2018: $37.5m
- Silverback Therapeutics, Inc. funding round, September 2018: $20m
- Silverback Therapeutics, Inc. funding round, March 2020: $78.7m
- Silverback Therapeutics, Inc. funding round, October 2020: $85m
- Silverback Therapeutics, Inc. funding round, April 2016: $60m
- Silverback Therapeutics Series C round September 2020: $85m
- Silverback Therapeutics, Inc. funding round, November 2016: $25k
- Silverback Therapeutics, Inc. funding round, January 2018: $3.75k
Industries
Silverback Therapeutics is active in the following industries: